Palmitoleic acid (16:1 cis-9) 3.2 ± 0.2 5.3 ± 0.1* 5.7 ± 0.2* Stearic acid (18:0) 15.5 ± 1.2 13.9 ± 0.1 13.9 ± 0.2
Elaidic acid (18:1 trans-9 ) 0 . 2 5 ± 0.05 0.25 ± 0.03 0.26 ± 0.05
Oleic acid (18:1 cis-9 ) 25.3 ± 0.2 27.5 ± 0.2* 27.3 ± 0.2* Vaccenic acid (18:1 cis-11) 8.9 ± 0.5 9.2 ± 0.6 9.1 ± 0.2 Linolenelaidic acid (18:2 trans 9, 12) 0.32 ± 0.02 0.5 ± 0.05* 0.5 ± 0.04* Linoleic acid (18:2 cis 9,12) 2.17 ± 0.2 1.0 ± 0.4* 1.3 ± 0.03* Gondoic acid (20:1cis-11) 1.4 ± 0.5 1.2 ± 0.03 1.4 ± 0.05
Eicosadienoic acid (20:2 cis-11,14 ) 2.6 ± 0.2 2.8 ± 0..05 2.6 ± 0.05
Eicosatrienoic acid (20:3 cis-8,11,14 ) 1.0 ± 0.03 0.9 ± 0.03 1.0 ± 0.03 Eicosatetraenoic acid (20:4 trans-5,8,11,14 ) 0.12 ± 0.05 0.15 ± 0.01 0.17 ± 0.02
Aracidonic acid (20:4 cis-5,8,11,14) 8.1 ± 0.3 6.5 ± 0.1* 6.4 ± 0.1* Eicosapentaenoic acid (20:5 cis-5,8,11,14,17) 0.4 ± 0.03 0.5 ± 0.03* 0.5 ± 0.03* Docosapentaenoic acid (22:5 cis-7,10,13,16,19 ) 0.9 ± 0.10 1.3 ± 0.02* 1.5 ± 0.05* Docosahexaenoic acid (22:6 cis-4,7,10,13,16,19 ) 4.1 ± 0.2 3.2 ± 0.03* 3.1 ± 0.05* INS-1E cells were incubated in serum-free medium supplemented with the indicated glucose concentration for 16 h, and processed for lipidomics analysis. Data are given as percent of total fatty acid content. Mean ± SEM, n=4. *P < 0.05 significantly different from the 5 mM glucose incubation.
The following fatty acids were determined: 16:0 (palmitic acid); 16:1 (cis-9-hexadecenoic acid, palmitoleic acid); 18:0 (stearic acid); 18:1 (trans-9-octadecenoic acid, elaidic acid); 18:1 (cis-9-octadecenoic acid, oleic acid); 18:1 (cis-11-ocatadecenoic acid, cis-vaccenic acid); 18:2 (trans-9,12-octadecadienoic acid, linolenelaidic acid); 18:2 (cis-9,12-octadecadienoic acid ( 
